General Atlantic announced on April 9 that it acquired U.S. Urology Partners from NMS Capital.  

U.S. Urology Partners provides management expertise and infrastructure resources across several areas, including provider recruitment, payor contracting, data analytics and compliance. It was a portfolio company of NMS Capital. 

General Atlantic is a growth equity firm providing capital and strategic support for global growth companies. It was founded in 1980. 

Houlihan Lokey served as lead financial advisor to U.S. Urology Partners and NMS Capital. Ernst & Young Capital Advisors also served as financial advisor to NMS Capital. McDermott Will & Emery provided legal counsel to U.S. Urology Partners and NMS Capital.  

The investment strengthens U.S. Urology Partners’ position as a partner to independent community-based urology practices that enables them to focus on delivering premier care to the patients they serve. Terms were not disclosed.  

According to data in the LevinPro HC database, this transaction represents the 121st Physician Medical Group acquisition of 2025 and the second in the management services organization (MSO) specialty. In 2024, 15 MSO transactions were announced.